-transparent.png){kind=logo}
Hemostatic function was studied sequentially in 12 children receiving L-asparaginase, vincristine, and prednisone as remission induction chemotherapy for acute lymphoblastic leukemia. The three-week period of L-asparaginase therapy was characterized by progressive decreases in plasma antithrombin, plasminogen, and fibrinogen concentrations, and by progressive increases in plasma clotting times (prothrombin time, partial thromboplastin time, thrombin time). Platelet counts rose rapidly during the third and fourth weeks of therapy as bone marrow remission was achieved. Factor V levels increased steadily during a five-week period, perhaps related to vincristine or prednisone therapy. Recent reports of thrombosis and hemorrhage in children and adults receiving L-asparaginase may be explained by this complex set of abnormalities in coagulation and coagulation control.
J R Priest, and
N K Ramsay, and
A J Bennett, and
W Krivit, and
J R Edson
May 1986,
The Journal of pediatrics,
J R Priest, and
N K Ramsay, and
A J Bennett, and
W Krivit, and
J R Edson
October 1977,
Cancer,
J R Priest, and
N K Ramsay, and
A J Bennett, and
W Krivit, and
J R Edson
August 2008,
Thrombosis and haemostasis,
J R Priest, and
N K Ramsay, and
A J Bennett, and
W Krivit, and
J R Edson
July 2019,
Pediatric blood & cancer,
J R Priest, and
N K Ramsay, and
A J Bennett, and
W Krivit, and
J R Edson
January 2014,
Indian journal of cancer,
J R Priest, and
N K Ramsay, and
A J Bennett, and
W Krivit, and
J R Edson
February 1994,
Annals of hematology,
J R Priest, and
N K Ramsay, and
A J Bennett, and
W Krivit, and
J R Edson
December 2002,
Pediatric hematology and oncology,
J R Priest, and
N K Ramsay, and
A J Bennett, and
W Krivit, and
J R Edson
December 2000,
The Medical journal of Malaysia,
J R Priest, and
N K Ramsay, and
A J Bennett, and
W Krivit, and
J R Edson
June 2021,
Thrombosis journal,
J R Priest, and
N K Ramsay, and
A J Bennett, and
W Krivit, and
J R Edson
March 2017,
Journal of pediatric hematology/oncology,
